Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study
Crossref DOI link: https://doi.org/10.1007/s00223-014-9927-7
Published Online: 2014-11-07
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hagino, Hiroshi
Yoshida, Seitaro
Hashimoto, Junko
Matsunaga, Masayuki
Tobinai, Masato
Nakamura, Toshitaka
License valid from 2014-11-07